Related Experiment Video
Updated: Jul 19, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Motor fluctuations in Parkinson's disease
1Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, USA.
Reviews in Neurological Diseases
|October 19, 2006
Summary
Parkinson's disease management involves addressing motor fluctuations like "end-of-dose wearing-off" with levodopa. Treatment options include adjusting medication, adding other drugs, or considering deep brain stimulation for severe cases.
Area of Science:
- Neurology
- Movement Disorders
Background:
- Parkinson's disease (PD) is a progressive neurodegenerative disorder causing bradykinesia, rigidity, and tremor.
- Levodopa is a primary treatment for motor dysfunction in PD, but motor fluctuations are common.
- Motor fluctuations include "end-of-dose wearing-off" and "morning akinesia," where PD symptoms return as medication wears off.
Purpose of the Study:
- To review the management strategies for motor fluctuations in Parkinson's disease.
- To discuss the various pharmacological and non-pharmacological options available.
Main Methods:
- Review of existing literature on Parkinson's disease motor fluctuations.
- Discussion of therapeutic options including medication adjustments and additions.
- Consideration of surgical interventions like deep brain stimulation.
Main Results:
- Motor fluctuations are a significant challenge in long-term Parkinson's disease management.
- Treatment choices involve adjusting levodopa/carbidopa dosage or adding other medications.
- Available adjunct therapies include dopamine agonists, COMT inhibitors, MAO inhibitors, and amantadine.
- Dietary changes can also play a role in managing motor fluctuations.
Conclusions:
- Managing motor fluctuations in Parkinson's disease requires a personalized approach.
- While head-to-head comparisons of adjunct therapies are limited, various options offer potential benefits.
- Deep brain stimulation is a viable option for patients with medically intractable motor fluctuations.
More Related Videos
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

